[1]
“Long-Term Effect of Dupilumab With Concomitant Topical Corticosteroids on POEM in Adults With Moderate-to-Severe Atopic Dermatitis: LIBERTY AD CHRONOS Trial”, J of Skin, vol. 4, no. 5, p. s50, Sep. 2020, doi: 10.25251/skin.4.supp.49.